help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on February 1, 2007, doi:10.1165/rcmb.2006-0359OC

Am. J. Respir. Cell Mol. Biol., Volume 36, Number 6, June 2007, 678-687

A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0359OCv1
36/6/678    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, Y. J
Right arrow Articles by Day, R. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, Y. J
Right arrow Articles by Day, R. M

Submitted on September 23, 2006
Revised on February 1, 2007

Regulation of Bcl-xL Expression in Lung Vascular Smooth Muscle

Yuichiro J Suzuki1*, Hiroko Nagase1, Chi Ming Wong1, Shilpashree Vinod Kumar1, Vivek Jain2, Ah-Mee Park1, and Regina M Day3

1 Department of Pharmacology, Georgetown University Medical Center, Washington, DC, USA, 2 Department of Medicine, Division of Pulmonary and Critical Care Medicine, George Washington University Medical Center, Washington, DC, USA, 3 Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

* To whom correspondence should be addressed. E-mail: ys82{at}georgetown.edu.

Pulmonary hypertension is characterized by thickened pulmonary arterial walls due to increased number of pulmonary artery smooth muscle cells (PASMC). Apoptosis of PASMC may play important roles in regulating the PASMC number and may be useful for reducing pulmonary vascular thickening. The present study examined the regulation of an anti-apoptotic protein Bcl-xL. Bcl-xL expression was found to be increased in the pulmonary artery of chronic hypoxia treated rats with pulmonary vascular remodeling. Adenovirus-mediated gene transfer of Bcl-xL indeed showed that this protein has anti-apoptotic activities in PASMC. Treatment of remodeled pulmonary artery with sodium nitroprusside (SNP) reduced Bcl-xL expression by targeting the bcl-xL promoter. The bcl-xL promoter contains two GATA elements, and SNP decreases the GATA-4 DNA binding activity. Overexpression of GATA-4 attenuated the SNP-mediated suppression of Bcl-xL expression, providing direct evidence for the role of GATA-4 in Bcl-xL gene transcription. We identified that SNP targets the 250 proximal region of the gata4 promoter and suppresses its gene transcription. Thus, inducers of pulmonary hypertension enhance anti-apoptotic Bcl-xL gene transcription, which can be suppressed by targeting the gata4 gene transcription.




This article has been cited by other articles:


Home page
Circ. Res.Home page
C. M. Wong, A. K. Cheema, L. Zhang, and Y. J. Suzuki
Protein Carbonylation as a Novel Mechanism in Redox Signaling
Circ. Res., February 15, 2008; 102(3): 310 - 318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  2009/2010 ATS Fellows Career Development Awards